Conclusions The results of this large population-based cohort study indicate that in patients with NAFLD and type 2 diabetes, GLP-1RAs and SGLT2 inhibitors are associated with lower incidences of macrovascular diseases and all-cause mortality compared with other glucose-lowering drugs
Critical adjustments by food manufacturers, food and consumable bricks-and-mortar retailers, as well as food direct-to-consumer companies, can help to maintain profitability in a reshaped food market
The injectable version aligns exactly with most clinical studies and the regimen employed by Ozempic and Wegovy
After it enters the subcutaneous tissue, the lipids organize themselves into a gel
CMS delays Part D GLP-1 model amid skepticism from insurers. April 21, 2026
Muscle loss associated with the use of GLP-1 drugs can be mitigated by consuming a protein-rich diet and regular exercise